cached image

Andrew V. Schally, MD, PhD

Affiliations: 
1957-1962 Physiology Baylor College of Medicine, Houston, TX 
 1962- Endocrinology Tulane Medical School, New Orleans, LA, United States 
Area:
Endocrinology
Website:
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1977/schally-bio.html
Google:
"Andrew V. Schally"
Bio:

http://www.nasonline.org/member-directory/members/50830.html
The Nobel Prize in Physiology or Medicine 1977 was divided, one half jointly to Roger Guillemin and Andrew V. Schally for their discoveries concerning the peptide hormone production of the brain and the other half to Rosalyn Yalow for the development of radioimmunoassays of peptide hormones.

Mean distance: 19.27 (cluster 7)
 
SNBCP
Cross-listing: Chemistry Tree

Parents

Sign in to add mentor
Murray Saffran grad student 1957 McGill

Collaborators

Sign in to add collaborator
Roger Guillemin collaborator 1957-1962 Baylor
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gesmundo I, Granato G, Fuentes-Fayos AC, et al. (2021) Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling. Cancers. 13
Barabutis N, Akhter MS, Uddin MA, et al. (2020) GHRH Antagonists Protect Against Hydrogen Peroxide-Induced Breakdown of Brain Microvascular Endothelium Integrity. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 52: 336-339
Recinella L, Chiavaroli A, Orlando G, et al. (2020) Publisher Correction: Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice. Scientific Reports. 10: 4850
Uddin MA, Akhter MS, Singh SS, et al. (2019) GHRH antagonists support lung endothelial barrier function. Tissue Barriers. 1669989
Zhang C, Cai R, Lazerson A, et al. (2019) Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin. Lung
Villanova T, Gesmundo I, Audrito V, et al. (2019) Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Proceedings of the National Academy of Sciences of the United States of America
Schally AV, Wang H, He J, et al. (2018) Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH. Proceedings of the National Academy of Sciences of the United States of America
Qin YJ, Chu WK, Huang L, et al. (2018) Induction of Apoptosis in Pterygium Cells by Antagonists of Growth Hormone-Releasing Hormone Receptors. Investigative Ophthalmology & Visual Science. 59: 5060-5066
Oláh G, Dobos N, Vámosi G, et al. (2018) Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152). European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 123: 371-376
Cui T, Schally AV. (2018) Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1. Oncotarget. 9: 28745-28756
See more...